tiprankstipranks
Trending News
More News >
Genmab A/S (GMAB)
NASDAQ:GMAB
Advertisement

Genmab (GMAB) Similar Stocks

Compare
641 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Genmab
$23.63
$14.07B
12.84
-16.00%
4 Buy
2 Hold
0 Sell
Moderate Buy
BioMarin Pharmaceutical
$59.76
$11.44B
22.14
-30.18%
15 Buy
5 Hold
0 Sell
Strong Buy
Exelixis
$44.79
$12.38B
20.60
95.08%
10 Buy
8 Hold
0 Sell
Moderate Buy
Incyte
$70.49
$13.68B
218.72
2.80%
7 Buy
9 Hold
1 Sell
Moderate Buy
United Therapeutics
$306.41
$13.82B
12.23
-8.91%
9 Buy
3 Hold
0 Sell
Strong Buy
Ascendis Pharma
$168.31
$10.27B
25.25%
15 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GMAB
Genmab
23.63
-4.75
-16.74%
BMRN
BioMarin Pharmaceutical
59.76
-24.83
-29.35%
EXEL
Exelixis
44.79
21.40
91.49%
INCY
Incyte
70.49
1.88
2.74%
UTHR
United Therapeutics
306.41
-31.81
-9.41%
ASND
Ascendis Pharma
168.31
34.56
25.84%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis